We are a multi-disciplinary group of surgeons, radiologists, pathologists, medical oncologists, genomicists, immunologists and epidemiologists whose goal is to prevent, diagnose, treat and improve the lives of patients with lung cancer diseases.
Together, we search for improved imaging methods that detect lung cancer lesions as early as possible during tumor progression. We also study how tumor cell genetics and tumor cells interactions with its surrounding cellular microenvironment contribute to tumor outcome. We are particularly interested in exploring how the tumor immune cell microenvironment contribute to disease course and tumor response to immunotherapy, targeted therapies and conventional treatment with the ultimate goal of harnessing immune cell biology to improve antitumor therapies.
This group also oversees the distribution and utilization of lung tissue specimens in the context of growing research demand and aim to facilitate the ongoing innovative lung cancer research at Mount Sinai aimed at deepening our knowledge of this disease and finding new ways to fight it.